Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabian Vandermeers
Observed names:
F Vandermeers,
F. Vandermeers,
Vandermeers F.,
Vandermeers, F.,
Vandermeers, Fabian
Observed institutions:
Université Libre de Bruxelles,
University of Liège,
Fund for Scientific Research,
Georgetown University,
Gembloux Agro-Bio Tech,
Institut Jules Bordet,
Veterinary and Agrochemical Research Centre,
National Veterinary Research Institute,
University of Pennsylvania
show all 9
OpenAlex ID:
A5047336283
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human
2007
·
Nicolas Gillet
, Arnaud Florins
, et al.
·
Retrovirology
·
400
PDF
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cellsin vitroandin vivowith particular efficacy for small cell lung cancer
2009
·
M. Cecilia Crisanti
, Africa F. Wallace
, et al.
·
Molecular Cancer Therapeutics
·
124
PDF
Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
2009
·
Fabian Vandermeers
, Pascale Hubert
, et al.
·
Clinical Cancer Research
·
92
PDF
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo
2005
·
Amine Achachi
, Arnaud Florins
, et al.
·
Proceedings of the National Academy of Sciences
·
68
The role of epigenetics in malignant pleural mesothelioma
2013
·
Fabian Vandermeers
, Sathya Neelature Sriramareddy
, et al.
·
Lung Cancer
·
49
Emphasis on cell turnover in two hosts infected by bovine leukemia virus: A rationale for host susceptibility to disease
2008
·
Arnaud Florins
, Mathieu Boxus
, et al.
·
Veterinary Immunology and Immunopathology
·
44
Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy
2010
·
Roland Hubaux
, Fabian Vandermeers
, et al.
·
European Journal of Cancer
·
39
Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models
2015
·
Roland Hubaux
, Fabian Vandermeers
, et al.
·
ERJ Open Research
·
14
PDF
Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors
2012
·
Nicolas Gillet
, Fabian Vandermeers
, et al.
·
Pathogens
·
9
PDF
TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma
2020
·
Bernard Staumont
, Majeed Jamakhani
, et al.
·
Cancers
·
4
PDF
Implication des modifications épigénétiques dans les cancers : développement de nouvelles approches thérapeutiques
2008
·
Willems L.
, Vandermeers F.
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
2
[Cellular dynamics of pathogenesis induced by bovine leukemia virus].
2007
·
A Florins
, N Gillet
, et al.
·
PubMed
·
2
Abstract 984: The role of TGF-alpha in the resistance to mesothelioma chemotherapy.
2013
·
Sathya Neelature Sriramareddy
, Fabian Vandermeers
, et al.
·
Cancer Research
·
1
A new treatment combining valproate acid (VA) plus doxorubicin (D) for patients with refractory or recurrent malignant mesothelioma (MM): a phase II study
2009
·
Arnaud Scherpereel
, Thierry Berghmans
, et al.
·
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
·
1
EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma.
2017
·
Bernard Staumont
, Christostome Costa
, et al.
·
ORBi (University of Liège)
Abstract 4478: EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma
2016
·
Bernard Staumont
, Chrisostome Costa
, et al.
·
Cancer Research
Validation of analytical methods for in-process characterization of human mesenchymal stem cells used for clinical studies
2014
·
N. Theys
, S. Thys
, et al.
·
Cytotherapy
From IPSC to MSC-like : cell lineages success and their in-process monitoring by specific flow cytometry markers
2014
·
N. Theys
, V. Deffontaine
, et al.
·
Cytotherapy
Validation of a nucleic acid amplification technique for the detection of mycoplasma in cell-based medicinal products (CBMPs)
2014
·
N. Theys
, F. Vandermeers
·
Cytotherapy
Abstract 2566: Beneficial impact of valproate on the response of small cell lung cancer to cisplatin – etoposide therapy
2011
·
Fabian Vandermeers
, Roland Hubaux
, et al.
·
Cancer Research
Corrigendum to “Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy” [Eur. J. Cancer 46(9) (2010) 1724-1734]
2010
·
Roland Hubaux
, Fabian Vandermeers
, et al.
·
European Journal of Cancer
Preclinical evidences for a beneficial impact of valproate in response of small cell lung cancer to first-line chemotherapy.
2010
·
Hubaux, F.
, Vandermeers, F.
, et al.
·
ORBi UMONS
Valproate, in combination with pemetrexed and cisplatin, provideds additional efficacy to the treatment of malignant mesothelioma.
2009
·
Vandermeers, F.
, Hubert, P.
, et al.
·
ORBi UMONS
Thérapie du mésothéliome pleural malin par l’utilisation du valproate, un inhibiteur de désacétylases
2008
·
Fabian Vandermeers
·
Open Repository and Bibliography (University of Liège)
Dynamique cellulaire de la pathogenèse induite par le virus de la leucémie bovine
2007
·
Arnaud-Francois Florins
, Nicolas Gillet
, et al.
·
ORBi (University of Liège)
Show more works
View as search
Works count:
33
Citation count:
849
H-index:
9
I10-index:
8
Year
Topic
Type